NeuroOne reported third quarter fiscal 2026 product revenue of $1.97 million, a 16% year-over-year increase that fell short of the $2.5 million analyst estimate. Despite the revenue miss and a lowered full-year outlook, the company achieved record product gross margins of 59.9% and reported that new product orders of $2.7 million outpaced actual shipments during the period.
Key Highlights
- Product revenue grew 16% YoY to $1.97 million, missing the $2.5 million consensus as manufacturing and shipment timing delayed revenue recognition.
- Product gross margins expanded 600 basis points to 59.9% from 53.9% in the prior-year period, driven by a favorable shift toward higher-margin OneRF products.
- Management lowered fiscal year 2026 revenue guidance to a range of $9.2 million–$10.5 million, significantly down from the previous expectations of $12 million–$15 million.
- Net loss widened to $2.0 million, or $0.23 per basic share, compared to a loss of $1.5 million in the same year-ago quarter.